Literature DB >> 7282789

Treatment of vulvovaginal candidiasis with boric acid powder.

K K Van Slyke, V P Michel, M F Rein.   

Abstract

A double-blind comparison was made of the use of 14 daily intravaginal gelatin capsules containing 600 mg of boric acid powder versus the use of identical capsules containing 100,000 U nystatin diluted to volume with cornstarch for the treatment of vulvovaginal candidiasis albicans. Cure rates for boric acid were 92% at 7 to 10 days after treatment and 72% at 30 days, whereas the nystatin cure rates were 64% at 7 to 10 days and 50% at 30 days. The speed of alleviation of signs and symptoms was similar for the two drugs. There were no untoward side effects, and cervical cytologic features were not affected. In vitro studies found boric acid to be fungistatic and its effectiveness to be unrelated to pH. Blood boron analyses indicated little absorption from the vagina and a half-life of less than 12 hours. Acceptance by the patients was better than for "messy" vaginal creams, and self-made capsules containing boric acid powder are inexpensive (31 cents for fourteen) compared with the costly medication commonly prescribed.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7282789     DOI: 10.1016/s0002-9378(16)32581-9

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  8 in total

Review 1.  Candidiasis (vulvovaginal).

Authors:  Des Spence
Journal:  BMJ Clin Evid       Date:  2010-01-05

Review 2.  Vaginitis: current microbiologic and clinical concepts.

Authors:  L V Hill; J A Embil
Journal:  CMAJ       Date:  1986-02-15       Impact factor: 8.262

Review 3.  Evaluation and management of vaginitis.

Authors:  P L Carr; D Felsenstein; R H Friedman
Journal:  J Gen Intern Med       Date:  1998-05       Impact factor: 5.128

4.  Boric Acid and Commercial Organoboron Products as Inhibitors of Drug-Resistant Candida albicans.

Authors:  Bryan Larsen; Marija Petrovic; Francesco De Seta
Journal:  Mycopathologia       Date:  2017-10-09       Impact factor: 2.574

Review 5.  Boric acid vaginal suppositories: a brief review.

Authors:  S M Prutting; J D Cerveny
Journal:  Infect Dis Obstet Gynecol       Date:  1998

6.  BASIC study: is intravaginal boric acid non-inferior to metronidazole in symptomatic bacterial vaginosis? Study protocol for a randomized controlled trial.

Authors:  Melinda Zeron Mullins; Konia M Trouton
Journal:  Trials       Date:  2015-07-26       Impact factor: 2.279

Review 7.  Making inroads into improving treatment of bacterial vaginosis - striving for long-term cure.

Authors:  Catriona S Bradshaw; Rebecca M Brotman
Journal:  BMC Infect Dis       Date:  2015-07-29       Impact factor: 3.090

Review 8.  Bacterial Vaginosis Biofilms: Challenges to Current Therapies and Emerging Solutions.

Authors:  Daniela Machado; Joana Castro; Ana Palmeira-de-Oliveira; José Martinez-de-Oliveira; Nuno Cerca
Journal:  Front Microbiol       Date:  2016-01-20       Impact factor: 5.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.